2025-05-02 09:01:19
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Aurobindo Pharma Ltd Q1FY21 consolidated PAT at Rs. 780.68 crore
Posted On : 2020-08-12 20:49:06( TIMEZONE : IST )
AUROBINDO PHARMA LTD. has reported financial results for the period ended June 30, 2020.
Financial Results (Q1 FY 2020-21) - QoQ Comparison
The company has reported total income of Rs.5924.78 crores during the period ended June 30, 2020 as compared to Rs.6158.43 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.780.68 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.848.99 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.13.32 for the period ended June 30, 2020 as compared to Rs.14.50 for the period ended March 31, 2020.
| Financials | Q1 FY2020-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 5924.78 crs | ₹ 6158.43 crs |  -3.79% |
| Net Profit | ₹ 780.68 crs | ₹ 848.99 crs | -8.05% |
| EPS | ₹ 13.32 | ₹ 14.50 | -8.14% |
Financial Results (Q1 FY 2020-21) - YoY Comparison
The company has reported total income of Rs.5924.78 crores during the period ended June 30, 2020 as compared to Rs.5444.60 crores during the period ended June 30, 2019.
The company has posted net profit / (loss) of Rs.780.68 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.635.68 crores for the period ended June 30, 2019.
The company has reported EPS of Rs.13.32 for the period ended June 30, 2020 as compared to Rs.10.85 for the period ended June 30, 2019.
| Financials | Q1 FY2020-21 | Q1 FY2019-20 | % Change |
| Total Income | ₹ 5924.78 crs | ₹ 5444.60 crs |  8.82% |
| Net Profit | ₹ 780.68 crs | ₹ 635.68 crs | 22.81% |
| EPS | ₹ 13.32 | ₹ 10.85 | 22.76% |
Commenting on the Company's performance, Mr. N. Govindarajan, Managing Director of the company said: "Amidst challenging times, we have started the financial year by reporting a healthy performance. We have ensured the business continuity without compromising the safety and wellbeing of our employees. We are committed to adhere to quality standards by investing continuously and developing a differentiated product pipeline for a sustainable growth".
Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.934 as compared to the previous close of Rs. 944.75. The total number of shares traded during the day was 329655 in over 8678 trades.
The stock hit an intraday high of Rs. 957.15 and intraday low of 922.6. The net turnover during the day was Rs. 309819577.
